AVL-8168

N/A

Report date: 2025/01/26 18:07:31
NME

Base Information

Drug NameAVL-8168
Drug Alias NameAVL-8168
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit agonistsGamma-aminobutyric acid A receptor alpha-5 inhibitors
TargetsNeuronal acetylcholine receptor protein alpha-7 subunitGamma-aminobutyric acid A receptor alpha-5
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnvyl LLC
China Registration ClassN/A

Develop Information

Active CompaniesAnvyl LLC
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A